EcoDrugPlus

Cyclin Dependent Kinase 9

Ensembl ID : ENSPLOG00000019809
Gene Symbol: CDK9
2 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSPLOG00000017757
Gene Symbol: CYSLTR1
2 Cross references
177 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSPLOG00000012061
Gene Symbol: CDA
4 Cross references
224 Possible Orthologues:

Cytochrome P450 11b1, Mitochondrial

Ensembl ID : ENSPLOG00000000535
Gene Symbol: LOC122210855
3 Cross references
45 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSPLOG00000016900
Gene Symbol: CYP17A1
4 Cross references
210 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSPLOG00000003924
Gene Symbol: CYP19A1
4 Cross references
315 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSPLOG00000013834
Gene Symbol: CYP26A1
4 Cross references
207 Possible Orthologues:

Cytochrome P450 Family 3 Subfamily A Member 131

Ensembl ID : ENSPLOG00000021657
Gene Symbol: CYP3A131
4 Cross references
671 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSPLOG00000021599
Gene Symbol: CYP46A1
2 Cross references
259 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSPLOG00000021992
Gene Symbol: DGAT1
4 Cross references
260 Possible Orthologues:

Dihydrofolate Reductase

Ensembl ID : ENSPLOG00000000207
Gene Symbol: DHFR
3 Cross references
350 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSPLOG00000011264
Gene Symbol: DHODH
4 Cross references
173 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).